Shareholders' Equity - Schedule of Expenses Recognized Financial Statements (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
| Schedule of Expenses Recognized Financial Statements [Line Items] | |||||
| Expenses recognized | $ 362 | $ 261 | $ 263 | ||
| Research and development [Member] | |||||
| Schedule of Expenses Recognized Financial Statements [Line Items] | |||||
| Expenses recognized | 75 | 83 | 137 | ||
| General and administrative [Member] | |||||
| Schedule of Expenses Recognized Financial Statements [Line Items] | |||||
| Expenses recognized | [1] | $ 287 | $ 178 | $ 126 | |
| |||||
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|